Clinical Trials Browser

Phase 1 × PROSTVAC × Genitourinary × Clear all

NCT03532217 2022-08-05

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Phase 1 Completed

Metastatic Hormone-Sensitive Prostate Cancer

NCT00001382 2008-03-04

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Phase 1 Completed

Prostatic Neoplasms